About

My name is Charlie Petty, and I'm a life sciences and technology investor living in New York City with my wife and two young children. I work at Stripe.

Before Stripe, I worked at the Global Health Investment Corporation and co-founded Adjuvant Capital, an investment firm focused on global public health. Previously, I worked for the Global Health Investment Fund and Artemis Capital Partners (and its predecessor firm, Axia Partners). For two years after college, I lived in Haiti and worked as a financial analyst for the country's largest microfinance bank.

I serve on corporate boards including Aceris Biosciences, Curevo Vaccine (acquired by Eli Lilly), and Terrestrial Bio. I led or co-led investments in Vaccine Company (acquired by Eli Lilly), Alydia Health (acquired by Merck), Iantech (acquired by Carl Zeiss), Medicines Development for Global Health (PRV acquired by Novo Nordisk), Eubiologics (KOSDQ listed), Minervax, Vitrivax, Centivax, Excision Biotechnologies, ChromaCode, and Codagenix.

I serve on a number of nonprofit boards, including the Council on Strategic Risks, Blueprint Biosecurity, ProEquip Inc., and the Mirror Biology Dialogues Fund.